Morgan L. Maeder

17.3k total citations · 6 hit papers
41 papers, 11.4k citations indexed

About

Morgan L. Maeder is a scholar working on Molecular Biology, Genetics and Plant Science. According to data from OpenAlex, Morgan L. Maeder has authored 41 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 6 papers in Genetics and 6 papers in Plant Science. Recurrent topics in Morgan L. Maeder's work include CRISPR and Genetic Engineering (31 papers), Advanced biosensing and bioanalysis techniques (16 papers) and RNA Interference and Gene Delivery (13 papers). Morgan L. Maeder is often cited by papers focused on CRISPR and Genetic Engineering (31 papers), Advanced biosensing and bioanalysis techniques (16 papers) and RNA Interference and Gene Delivery (13 papers). Morgan L. Maeder collaborates with scholars based in United States, Germany and France. Morgan L. Maeder's co-authors include J. Keith Joung, Yanfang Fu, Jeffry D. Sander, Deepak Reyon, Cyd Khayter, Jing-Ruey Joanna Yeh, Randall T. Peterson, Shengdar Q. Tsai, Woong Y. Hwang and Charles A. Gersbach and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Morgan L. Maeder

41 papers receiving 11.1k citations

Hit Papers

High-frequency off-target... 2009 2026 2014 2020 2013 2013 2014 2013 2009 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
    2013 2.5k citations Yanfang Fu, Cyd Khayter et al. Nature Biotechnology profile →
  2. Efficient genome editing in zebrafish using a CRISPR-Cas system
    2013 2.2k citations Woong Y. Hwang, Yanfang Fu et al. Nature Biotechnology profile →
  3. Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo
    2014 1.2k citations John A. Zuris, David B. Thompson et al. Nature Biotechnology profile →
  4. CRISPR RNA–guided activation of endogenous human genes
    2013 926 citations Morgan L. Maeder, Samantha J Linder et al. Nature Methods profile →
  5. High-frequency modification of plant genes using engineered zinc-finger nucleases
    2009 500 citations Fengli Fu, Morgan L. Maeder et al. profile →
  6. Genome-editing Technologies for Gene and Cell Therapy
    2016 472 citations Morgan L. Maeder, Charles A. Gersbach Molecular Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morgan L. Maeder United States 27 10.3k 2.5k 1.4k 866 816 41 11.4k
Deepak Reyon United States 28 10.3k 1.0× 2.4k 0.9× 1.6k 1.2× 937 1.1× 840 1.0× 40 11.8k
Jeffry D. Sander United States 31 12.6k 1.2× 3.1k 1.2× 2.0k 1.5× 1.0k 1.2× 926 1.1× 41 14.2k
Robert P. J. Barretto United States 10 10.4k 1.0× 2.4k 0.9× 1.3k 1.0× 727 0.8× 507 0.6× 12 12.6k
Shengdar Q. Tsai United States 37 12.6k 1.2× 3.1k 1.2× 1.4k 1.0× 1.4k 1.6× 663 0.8× 65 14.1k
Ophir Shalem United States 21 11.6k 1.1× 2.3k 0.9× 935 0.7× 822 0.9× 585 0.7× 42 13.1k
Yanfang Fu United States 16 7.3k 0.7× 1.7k 0.7× 736 0.5× 708 0.8× 677 0.8× 19 8.1k
Charles A. Gersbach United States 53 13.5k 1.3× 3.5k 1.4× 1.4k 1.1× 976 1.1× 504 0.6× 130 15.6k
Wenyan Jiang China 19 13.7k 1.3× 3.3k 1.3× 1.6k 1.2× 1.0k 1.2× 482 0.6× 39 15.5k
Prashant Mali United States 40 16.4k 1.6× 3.3k 1.3× 1.4k 1.1× 1.1k 1.2× 505 0.6× 96 17.8k
Fyodor D. Urnov United States 39 11.6k 1.1× 3.6k 1.4× 1.4k 1.0× 668 0.8× 605 0.7× 84 13.4k

Countries citing papers authored by Morgan L. Maeder

Since Specialization
Citations

This map shows the geographic impact of Morgan L. Maeder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morgan L. Maeder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morgan L. Maeder more than expected).

Fields of papers citing papers by Morgan L. Maeder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morgan L. Maeder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morgan L. Maeder. The network helps show where Morgan L. Maeder may publish in the future.

Co-authorship network of co-authors of Morgan L. Maeder

This figure shows the co-authorship network connecting the top 25 collaborators of Morgan L. Maeder. A scholar is included among the top collaborators of Morgan L. Maeder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morgan L. Maeder. Morgan L. Maeder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tremblay, Francine, Kevin R. Kelly, Svati H. Shah, et al.. (2024). An epigenetic editor targeting human PCSK9 efficiently and durably lowers Low Density Lipoprotein Cholesterol (LDL-C) in non-human primates. European Heart Journal. 45(Supplement_1). 2 indexed citations
2.
Giannoukos, Georgia, Dawn Ciulla, Eugenio Marco, et al.. (2018). UDiTaS™, a genome editing detection method for indels and genome rearrangements. BMC Genomics. 19(1). 212–212. 93 indexed citations
3.
Fajardo, Diego, Jim Peterson, Christianne E. Strang, et al.. (2018). Somatic Gene Editing of GUCY2D by AAV-CRISPR/Cas9 Alters Retinal Structure and Function in Mouse and Macaque. Human Gene Therapy. 30(5). 571–589. 66 indexed citations
4.
Stefanidakis, Michael, Morgan L. Maeder, George S. Bounoutas, et al.. (2018). Efficient in vivo editing of CEP290 IVS26 by EDIT-101 as a novel therapeutic for treatment of Leber Congenital Amaurosis 10. Investigative Ophthalmology & Visual Science. 59(9). 385–385. 2 indexed citations
5.
Maeder, Morgan L. & Charles A. Gersbach. (2016). Genome-editing Technologies for Gene and Cell Therapy. Molecular Therapy. 24(3). 430–446. 472 indexed citations breakdown →
6.
Friedland, Ari E., Pankhuri Singhal, Shen Shen, et al.. (2015). Characterization of Staphylococcus aureus Cas9: a smaller Cas9 for all-in-one adeno-associated virus delivery and paired nickase applications. Genome biology. 16(1). 257–257. 223 indexed citations
7.
Zuris, John A., David B. Thompson, Yilai Shu, et al.. (2014). Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nature Biotechnology. 33(1). 73–80. 1160 indexed citations breakdown →
8.
Hwang, Woong Y., Yanfang Fu, Deepak Reyon, et al.. (2013). Heritable and Precise Zebrafish Genome Editing Using a CRISPR-Cas System. PLoS ONE. 8(7). e68708–e68708. 278 indexed citations
9.
Maeder, Morgan L., Samantha J Linder, Vincent Cascio, et al.. (2013). CRISPR RNA–guided activation of endogenous human genes. Nature Methods. 10(10). 977–979. 926 indexed citations breakdown →
10.
Fu, Yanfang, Cyd Khayter, Morgan L. Maeder, et al.. (2013). High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nature Biotechnology. 31(9). 822–826. 2476 indexed citations breakdown →
11.
Hermann, Mario, Morgan L. Maeder, Burkhard Becher, et al.. (2012). Evaluation of OPEN Zinc Finger Nucleases for Direct Gene Targeting of the ROSA26 Locus in Mouse Embryos. PLoS ONE. 7(9). e41796–e41796. 33 indexed citations
12.
Lee, J., Ben S. Wittner, Morgan L. Maeder, et al.. (2011). Induction of Stable Drug Resistance in Human Breast Cancer Cells Using a Combinatorial Zinc Finger Transcription Factor Library. PLoS ONE. 6(7). e21112–e21112. 11 indexed citations
13.
Sebastiano, Vittorio, Morgan L. Maeder, Cyd Khayter, et al.. (2011). In Situ Genetic Correction of the Sickle Cell Anemia Mutation in Human Induced Pluripotent Stem Cells Using Engineered Zinc Finger Nucleases. Stem Cells. 29(11). 1717–1726. 242 indexed citations
14.
Sander, Jeffry D., Morgan L. Maeder, Deepak Reyon, et al.. (2010). ZiFiT (Zinc Finger Targeter): an updated zinc finger engineering tool. Nucleic Acids Research. 38(Web Server). W462–W468. 269 indexed citations
15.
Thibodeau-Beganny, Stacey, Morgan L. Maeder, & J. Keith Joung. (2010). Engineering Single Cys2His2 Zinc Finger Domains Using a Bacterial Cell-Based Two-Hybrid Selection System. Methods in molecular biology. 649. 31–50. 8 indexed citations
16.
Sander, Jeffry D., Deepak Reyon, Morgan L. Maeder, et al.. (2010). Predicting success of oligomerized pool engineering (OPEN) for zinc finger target site sequences. BMC Bioinformatics. 11(1). 543–543. 17 indexed citations
17.
Foley, Jonathan E., Morgan L. Maeder, Joseph Pearlberg, et al.. (2009). Targeted mutagenesis in zebrafish using customized zinc-finger nucleases. Nature Protocols. 4(12). 1855–1868. 106 indexed citations
18.
Maeder, Morgan L., Stacey Thibodeau-Beganny, Jeffry D. Sander, Daniel F. Voytas, & J. Keith Joung. (2009). Oligomerized pool engineering (OPEN): an 'open-source' protocol for making customized zinc-finger arrays. Nature Protocols. 4(10). 1471–1501. 155 indexed citations
19.
Foley, Jonathan E., Jing-Ruey Joanna Yeh, Morgan L. Maeder, et al.. (2009). Rapid Mutation of Endogenous Zebrafish Genes Using Zinc Finger Nucleases Made by Oligomerized Pool ENgineering (OPEN). PLoS ONE. 4(2). e4348–e4348. 193 indexed citations
20.
Pruett‐Miller, Shondra M., Jon P. Connelly, Morgan L. Maeder, J. Keith Joung, & Matthew H. Porteus. (2008). Comparison of Zinc Finger Nucleases for Use in Gene Targeting in Mammalian Cells. Molecular Therapy. 16(4). 707–717. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deepak Reyon Breakdown of academic impact, for papers by Jeffry D. Sander Breakdown of academic impact, for papers by Robert P. J. Barretto Breakdown of academic impact, for papers by Shengdar Q. Tsai Breakdown of academic impact, for papers by Ophir Shalem Breakdown of academic impact, for papers by Yanfang Fu Breakdown of academic impact, for papers by Charles A. Gersbach Breakdown of academic impact, for papers by Wenyan Jiang Breakdown of academic impact, for papers by Prashant Mali Breakdown of academic impact, for papers by Fyodor D. Urnov
Rankless by CCL
2026